Adaptive Biotechnologies Corp
ADPT
71 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Aug 28 9:50 PM | Katey Einterz OwenDirector | Sale | 9,615 | $26.00 | $250.0K | 78,639(D) | View → |
| Aug 26, 2026 | Aug 26 8:13 PM | KATHERINE E OWEN | Proposed Sale | 9,615 | $26.00 | $250.0K | — | View → |
| Aug 20, 2026 | Aug 20 10:07 PM | Harlan Robins | Proposed Sale | 402,160 | $25.44 | $10.2M | — | View → |
| Aug 18, 2026 | Aug 20 9:55 PM | Robert HershbergDirector | Sale | 30,664 | $24.40 | $748.2K | 46,683(D) | View → |
| Aug 18, 2026 | Aug 20 12:15 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 278,676 | $24.48 | $6.8M | 2,180,518(D) | View → |
| Aug 17, 2026 | Aug 20 12:15 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 321,324 | $25.08 | $8.1M | 2,180,518(D) | View → |
| Aug 17, 2026 | Aug 20 12:07 AM | Peter M NeupertDirector | Sale | 124,690 | $25.15 | $3.1M | 130,625(D) | View → |
| Aug 19, 2026 | Aug 19 10:28 PM | Harlan Robins | Proposed Sale | 215,632 | $25.49 | $5.5M | — | View → |
| Aug 18, 2026 | Aug 18 10:17 PM | ROBERT M HERSHBERG | Proposed Sale | 30,664 | $24.40 | $748.3K | — | View → |
| Aug 18, 2026 | Aug 18 9:45 PM | Chad Robins | Proposed Sale | 278,676 | $24.56 | $6.8M | — | View → |
| Aug 18, 2026 | Aug 18 9:45 PM | Harlan Robins | Proposed Sale | 261,044 | $24.56 | $6.4M | — | View → |
| Aug 17, 2026 | Aug 17 9:20 PM | Harlan Robins | Proposed Sale | 300,992 | $24.77 | $7.5M | — | View → |
| Aug 17, 2026 | Aug 17 9:20 PM | Chad Robins | Proposed Sale | 321,324 | $24.77 | $8.0M | — | View → |
| Aug 17, 2026 | Aug 17 8:49 PM | PETER NEUPERT | Proposed Sale | 124,690 | $25.15 | $3.1M | — | View → |
| Aug 10, 2026 | Aug 12 11:33 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 3,000 | $25.00 | $75.0K | 396,989(D) | View → |
| Aug 10, 2026 | Aug 10 8:37 PM | SUSAN BOBULSKY | Proposed Sale | 3,000 | $24.93 | $74.8K | — | View → |
| Jul 30, 2026 | Aug 3 10:26 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 1,299 | $24.00 | $31.2K | 399,989(D) | View → |
| Jul 30, 2026 | Jul 30 8:38 PM | SUSAN BOBULSKY | Proposed Sale | 1,299 | $22.56 | $29.3K | — | View → |
| Jul 21, 2026 | Jul 23 11:34 PM | Harlan S RobinsChief Scientific Officer | Sale | 492,400 | $21.89 | $10.8M | 812,058(D) | View → |
| Jul 21, 2026 | Jul 21 9:20 PM | Harlan Robins | Proposed Sale | 492,400 | $22.58 | $11.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 15,122 | $12.14 | 403,539(D) | View → |
| Mar 9, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 403,939(D) | View → |
| Mar 6, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 415,820(D) | View → |
| Mar 3, 2026 | Mar 6 1:05 AM | Michelle Renee GriffinDirector | Option Exercise | 48,044 | $3.99 | 0(D) | View → |
| Mar 5, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 427,701(D) | View → |
| Mar 4, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 439,582(D) | View → |
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 451,463(D) | View → |
| Feb 4, 2026 | Feb 7 12:30 AM | Kyle PiskelChief Financial Officer | Option Exercise | 2,145 | $12.14 | 2,146(D) | View → |
← Previous
Page 4 of 4